www.fdanews.com/articles/156592-fda-accepts-new-drug-application-for-durect-8217-s-posidur
FDA Accepts New Drug Application for Durect’s Posidur
June 21, 2013
The FDA has accepted an NDA from specialty pharmacy Durect for its painkiller candidate Posidur.
Pharmaceutical Business Review
Pharmaceutical Business Review